• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Jen Wieczner

Stay informed with Jen Wieczner’s coverage and analysis.

Television crews wait outside the address where Nav Sarao Futures Limited  is registered, in Hounslow, London
FinanceThis is how much money the arrested trader made on the ‘flash crash’
By Jen WiecznerApril 23, 2015
PA: Mylan Headquarters
FinanceMylan plays monkey-in-the-middle of hostile takeover battles
By Jen WiecznerApril 21, 2015
Frederick's of Hollywood Third Annual Lingerie Auction to Benefit The TS Alliance
RetailBra retailer Frederick’s of Hollywood goes bust
By Jen WiecznerApril 17, 2015
Government lawyers don’t want Comcast and Time Warner Cable to merge
TechGovernment lawyers don’t want Comcast and Time Warner Cable to merge
By Jen WiecznerApril 17, 2015
FRANCE-ENERGY-GE
FinanceWhy GE could retake throne as king of all dividend stocks
By Jen WiecznerApril 10, 2015
Biotech “bubble” popped, time to buy again?
FinanceBiotech “bubble” popped, time to buy again?
By Jen WiecznerMarch 27, 2015
Tesla investors do the electric slide
Tesla investors do the electric slide
By Jen WiecznerMarch 25, 2015
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
FeaturesHow Biogen scored the most successful Alzheimer’s drug so far
By Jen WiecznerMarch 20, 2015
Biotech pros’ top 8 stock picks
TechBiotech pros’ top 8 stock picks
By Jen WiecznerMarch 9, 2015
Clinton Foundation appoints Donna Shalala as new leader
MPWClinton Foundation appoints Donna Shalala as new leader
By Jen WiecznerMarch 6, 2015
WeWork’s utopian vision of your future life—in the office
LeadershipWeWork’s utopian vision of your future life—in the office
By Jen WiecznerMarch 5, 2015
FRANCE-AGRICUTLURE-PIG-FARM
FinanceThis is the only commodity to fall more than oil
By Jen WiecznerFebruary 19, 2015
IL: Corporations In Illinois
FinanceFat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By Jen WiecznerFebruary 6, 2015
Earns Pfizer
FeaturesIn speed mode, FDA approves Pfizer’s big new drug early
By Jen WiecznerFebruary 4, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceAfter Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
1...
  • 45
  • 46
  • 47
  • 48
  • 49
...51
Most Popular
Success
Jeff Bezos wants the bottom half of earners to pay zero income tax—he says nurses making just $75K should save $12K a yearplaceholder alt text
By Preston ForeMay 21, 2026
Success
Despite a $500 million net worth, Shaq just finished his fourth degree. He warns graduates: 'Your character will take you further than your resume'placeholder alt text
By Preston ForeMay 20, 2026
Workplace Culture
Bolt CEO says he let go of his entire HR team for creating problems that didn’t exist: ‘Those problems disappeared when I let them go’ placeholder alt text
By Preston ForeMay 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.